SHUKRAPHAR

HealthcareDrug Manufacturers - Specialty & Generic0
Shukra Pharmaceuticals Limited
₹41.42
Previous trading day close · Data updates nightly
41/100
Below AvgResearch Score
Market Cap
N/A
P/E Ratio
63.13
Premium
P/B Ratio
22.16
Premium
ROE
15.9%
Decent
ROCE
43.0%
Excellent
Debt / Equity
0.06
Low debt
Div. Yield
0.0%
EV/EBITDA
41.56
Expensive
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
40/100
Growth
Revenue, EPS, profit growth
35/100
Valuation
PE, PB, EV/EBITDA vs sector
39/100
Risk
Debt levels, volatility, coverage
50/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
63.13(Premium)
Forward P/E
N/A
P/B Ratio
22.16(Premium)
P/S Ratio
22.72(Expensive)
EV/EBITDA
41.56(Expensive)
Dividend Yield
0.0%
5Y CAGR
152.3%(High growth)
Revenue Growth
270.1%(High)
Profitability
ROE
15.9%(Good)
ROCE
43.0%(Excellent)
ROA
11.6%(Efficient)
Net Margin
45.8%(High)
EBITDA Margin
54.3%
Financial Health
Debt to Equity
0.06(Low debt)
Current Ratio
3.79(Healthy)
Quick Ratio
3.21(Good)
Interest Coverage
27.41x(Comfortable)
Technical Indicators
Based on previous trading day close
Volume
11.13L
Shareholding Pattern
Promoter
51.0%
High confidence
FII
0.0%
DII / MF
0.1%
Share SHUKRAPHAR
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
SHUKRAPHAR Share Price - ₹41.42 | Research Score & Analysis | StockSage Pro